Literature DB >> 2027762

Analysis of the v-myb structural components important for transactivation of gene expression.

D M Bortner1, M C Ostrowski.   

Abstract

In order to define the domains of the v-myb protein that are important for transactivation of gene expression, we have studied transactivation by the v-myb gene and a set of v-myb deletion mutants using transient transfection assays in NIH 3T3 cells. Analysis of the set of v-myb deletion products demonstrated that a previously unidentified region in the carboxyl-terminal portion of the protein is required for transactivation. This region lies between amino acids 295-356 with respect to the 5' end of the v-myb gene. Switching the v-myb DNA binding domain with the DNA binding domain of the rat glucocorticoid receptor (rGR) switched the cis-element requirement for v-myb action: only reports containing glucocorticoid response elements were activated by myb-rGR fusion proteins. The carboxyl terminal region essential for transactivation by the intact v-myb gene was also necessary for transactivation by the rGR-fusion gene. Carboxyl-terminal deletion mutations that encompassed the novel transactivation region were able to block wild-type v-myb transactivation when tested in transient co-expression assays. In an unexpected sidelight to our studies, we could demonstrate that the lacZ gene present in the prokaryotic vector sequences contained a DNA element that fortuitously can act as a v-myb-dependent enhancer element, and that v-myb protein can bind to this element in vitro. The lacZ enhancer contains the myb consensus DNA binding site YAAC(G/T)G.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027762      PMCID: PMC333912          DOI: 10.1093/nar/19.7.1533

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues.

Authors:  T J Gonda; D K Sheiness; J M Bishop
Journal:  Mol Cell Biol       Date:  1982-06       Impact factor: 4.272

2.  Characterization of the v-myb DNA binding domain.

Authors:  T Oehler; H Arnold; H Biedenkapp; K H Klempnauer
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

3.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Mechanism of transcriptional activation by Sp1: evidence for coactivators.

Authors:  B F Pugh; R Tjian
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  A novel mediator between activator proteins and the RNA polymerase II transcription apparatus.

Authors:  R J Kelleher; P M Flanagan; R D Kornberg
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.

Authors:  S L Berger; W D Cress; A Cress; S J Triezenberg; L Guarente
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

7.  trans activation of gene expression by v-myb.

Authors:  C E Ibanez; J S Lipsick
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  ras oncogene activation of a VL30 transcriptional element is linked to transformation.

Authors:  R D Owen; D M Bortner; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

9.  Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.

Authors:  B Lüscher; E Christenson; D W Litchfield; E G Krebs; R N Eisenman
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

10.  Characterization of the sequence-specific interaction of mouse c-myb protein with DNA.

Authors:  K M Howe; C F Reakes; R J Watson
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

View more
  5 in total

1.  The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.

Authors:  M S Colman; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

2.  FAETL motif required for leukemic transformation by v-Myb.

Authors:  S L Fu; J S Lipsick
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

Authors:  R H Chen; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors.

Authors:  C Hernandez-Munain; M S Krangel
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

5.  Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes.

Authors:  M A Reddy; B S Yang; X Yue; C J Barnett; I L Ross; M J Sweet; D A Hume; M C Ostrowski
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.